CD30

CD30

Target · TNF receptor

CD30 TNF receptor superfamily member 8 · KI-1

CD30, encoded by the TNFRSF8 gene and also known as KI-1 or D1S166E, is a member of the tumour necrosis factor receptor superfamily. It is the receptor for CD30L (TNFSF8) and signals through NF-kappa-B in activated lymphocytes. Browse Assay Genie's current range of CD30 research reagents below, or read on for the biology behind the target.

Cell membrane receptorTNFR8 family memberActivated T and B cells
595 aa
Protein length
~64 kDa
Molecular weight
1p36.22
Gene locus
TNFR8 family
Protein family
Target information

What is CD30 (TNF receptor superfamily member 8)?

CD30 is a receptor for TNFSF8, also called CD30L. Ligand engagement regulates gene expression through activation of NF-kappa-B. The receptor is thought to play a role in the regulation of cellular growth and in the transformation of activated lymphoblasts. According to NCBI Gene, TRAF2 and TRAF5 can interact with CD30 and mediate the signal transduction that leads to NF-kappa-B activation.

The CD30 protein is a member of the TNF receptor superfamily and belongs to the TNFR8 family. UniProt records it at the cell membrane and in the cytoplasm. The receptor is expressed by activated, but not by resting, T and B cells, which makes it a marker of lymphocyte activation. The TNFRSF8 gene produces two alternatively spliced transcript variants that encode distinct isoforms. Mouse and rat both carry a Tnfrsf8 ortholog.

Functionally, CD30 is described as a positive regulator of apoptosis. It has also been shown to limit the proliferative potential of autoreactive CD8 effector T cells and to protect the body against autoimmunity. In the HGNC nomenclature the gene is listed within the CD molecules and the tumour necrosis factor receptor superfamily. Its previous symbols and names include KI-1, D1S166E and tumour necrosis factor receptor superfamily, member 8. Researchers studying lymphocyte activation, TNF receptor signalling and immune tolerance use CD30 as a reference point, whether they measure it with a CD30 antibody or a CD30 ELISA kit.

Lymphocyte activation

CD30 is expressed on activated but not resting T and B cells, so it is studied as a marker of lymphocyte activation state.

NF-kappa-B signalling

CD30 engages TRAF2 and TRAF5 to drive NF-kappa-B activation, making it a model for TNF receptor signal transduction.

Apoptosis regulation

CD30 acts as a positive regulator of apoptosis, which is relevant to studies of cell death control in activated lymphoid cells.

Autoimmunity and tolerance

CD30 limits the proliferative potential of autoreactive CD8 effector T cells and helps protect against autoimmunity.

Background

CD30 frequently asked questions

What does CD30 do?

CD30 is the receptor for CD30L (TNFSF8). It activates NF-kappa-B, may regulate growth and transformation of activated lymphoblasts, and acts as a positive regulator of apoptosis. It also limits autoreactive CD8 effector T cell proliferation. Check the datasheet of any product for its validated reactivity.

What are the other names for CD30 and TNFRSF8?

The gene symbol is TNFRSF8, and the protein is named tumour necrosis factor receptor superfamily member 8. Aliases include KI-1, CD30 and D1S166E. NCBI Gene reports two alternatively spliced transcript variants that encode distinct isoforms.

Is CD30 conserved in mouse and rat?

Yes. Mouse and rat each have an ortholog named Tnfrsf8. The human protein belongs to the TNFR8 family within the TNF receptor superfamily. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other TNF receptor superfamily members with products at Assay Genie, useful for comparing receptor signalling and immune regulation.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P28908; product specifications from Assay Genie datasheets.

CD30 Product listing